The Centers for Disease Control and Prevention had three choices Friday on its Title 42 Ebola order. It could withdraw the order in line with the World Health Organization's "no country should close borders" instruction. It could publicly defend the order against that instruction. It could leave the order standing without comment, as it had on Monday, Tuesday, Wednesday, and Thursday. Friday at noon, the agency chose a fourth option the paper did not name when it tracked the standing contradiction Thursday: it expanded the order. [1]

The Department of Health and Human Services published an interim final rule revising 42 CFR Part 71.40, the regulation under which the Title 42 authority operates. The original May 18 order, signed by NIH Director Jay Bhattacharya in his temporary capacity running the CDC, barred non-US citizens who had been in the Democratic Republic of Congo, Uganda, or South Sudan within 21 days from entering the United States for 30 days. [2] [3] Friday's revision struck the carve-out for lawful permanent residents. Green-card holders who had been in the three countries in the preceding 21 days are now also barred. [1] [4]

The agency's own statement names what the change does and does not do. "Applying this authority to lawful permanent residents for a limited period of time provides a balance between protecting public health and managing emergency response resources." [1] The rule does not "permanently bar lawful permanent residents from returning to the United States." It gives the CDC "discretionary authority to restrict entry when needed and allowed by law." [1] The rule does not address the WHO instruction.

What it does, in mechanical terms, is take the carve-out the May 21 paper named — that under Title 42's own logic, returning American aid workers carry the same Ebola risk as Congolese business travelers, and the original order's exemption "defeated the purpose" of the screening rationale — and resolve it not by exempting more people but by barring more. The same Title 42 authority Donald Trump's first administration used to expel almost 3 million migrants at the southern border during COVID is now being used in its public-health form, by a CDC director-in-acting who is also running NIH, to bar a class of people who hold valid US residency documents. [5]

The WHO instruction, unanswered

The Friday CDC statement does not name the World Health Organization. It does not quote WHO Director-General Tedros Adhanom Ghebreyesus's May 17 instruction that "no country should close borders" during the Bundibugyo outbreak. It does not engage with the WHO's analytic premise — that closing borders during an Ebola outbreak discourages reporting, increases informal travel, and makes outbreaks larger, not smaller. [6]

Tedros raised the regional risk classification to "very high" the same Friday, with the suspected death count moving to 177 and a new confirmed case in Sud-Kivu Province bringing DRC's affected provinces to three: Ituri, Nord-Kivu, and now Sud-Kivu. [7] The CDC's own situation summary, updated Friday, holds the toll at "744 suspected cases, 83 confirmed cases, and more than 150 suspected deaths," including two confirmed cases and one death in Uganda. [8]

The Infectious Diseases Society of America's Chief Executive Officer, Dr. Jeanne Marrazzo, MD, MPH, issued the most direct institutional rebuke Friday: "Public health policies that single out non-U.S. citizens won't prevent viruses from crossing our borders. Diseases don't recognize passports." [9] Africa CDC Director General Dr. Jean Kaseya, on May 19, made the parallel point through the continental lens: "generalised travel restrictions and border closures are not the solution to outbreaks. Such measures can create fear, damage economies, discourage transparency, complicate humanitarian and health operations." [10]

The CDC's Friday rule does not engage with either critique. The American public-health agency has now widened a contradiction with its sister international agency without publicly acknowledging the contradiction exists.

The Bundibugyo backdrop

Bundibugyo virus is the rare third species of Ebolavirus, distinct from the Zaire strain Ervebo vaccines protect against. The May 2026 outbreak is the third Bundibugyo outbreak ever recorded — 2007 Uganda, 2012 DRC, 2026 DRC. The case-fatality rate in prior outbreaks ran 30-50%. There is no licensed vaccine. No licensed therapeutics. Early supportive care reduces deaths; international intervention, with health workers and isolation infrastructure, is what reduces outbreaks. [11]

The first death in the current outbreak was a four-year-old child in Mongbwalu Health Zone, Ituri Province, who died April 24. Laboratory testing using Zaire-strain cartridges initially returned negative results because Bundibugyo is genetically distinct. The mismatch produced a roughly three-week diagnostic gap during which the virus circulated, in part through funeral processions involving open caskets. [11] By the WHO's May 16 Disease Outbreak News, the case count was 246 suspected, 80 deaths. By May 20, US News reported the WHO's case count had risen to "almost 600 suspected cases." By Friday, the suspected-death count is 177. [7] The trajectory has tripled in two weeks.

The Sabin Vaccine Institute / CEPI / Merck candidate vaccines are 6-12 months from Phase I trials, per the London School of Hygiene & Tropical Medicine. [12] Scientific American confirms an mRNA candidate in early development. [13] No deployable countermeasure exists. The WHO convened a vaccine-options consultation May 19; the Gavi Vaccine Alliance has been coordinating with CEPI on a candidate-vaccine pipeline. None of those candidates ships before December at the earliest.

The political question, not asked

Friday's CDC rule arrived on a day when the Trump administration's foreign-aid cuts received "renewed scrutiny" — US News' May 20 framing — as the outbreak worsens. PEPFAR cuts and reductions in CDC global-health funding are the structural backdrop the WHO instruction "support outbreak control at the source" implicitly references. Africa CDC's May 19 statement framed the alternative as "African solidarity, policy coherence, and alignment among Member States" through Africa CDC rather than through US channels. The May 17 African High-Level Ministerial Committee on Global Health Architecture, with 48 ministers in Geneva, agreed that "future strategic negotiations related to continental health security partnerships should increasingly be coordinated through Africa CDC." [10]

This is the structural inversion the paper has been tracking. The US response to Bundibugyo is narrowing inward — the Title 42 order expanded to green-card holders; flights from affected countries channeled to Washington-Dulles only; visa services paused at three embassies. Africa CDC's response is widening outward — a continental Public Health Emergency of Continental Security declared May 18, separate from the WHO's PHEIC; coordinated funding asks routed through the African Union. The US Friday rule made the inversion concrete on a US passport-class line.

What the paper said and what the agency answered

Thursday's standard said the CDC contradiction with WHO "stood for three days" with no withdrawal, modification, or public defense. The article's open question — whether the agency would withdraw, defend, or move on a different vector — was framed against three possible answers. The fourth answer, expansion, is the answer the paper's lost-science thread memo had not asked. It is also the answer that hardens the contradiction rather than resolves it.

The CDC's Friday statement closes with a sentence that reads, in context, as the closest the agency comes to a defense of its position: "During rapidly evolving outbreaks of highly dangerous diseases, this option is required to protect public health. Some lawful permanent residents may have close family or community ties abroad and may travel more frequently to affected regions. That travel can increase the chance of exposure to disease." [1]

That sentence concedes — implicitly — the IDSA critique. A green-card holder who travels frequently to DRC carries the same Ebola exposure risk as a US citizen who travels frequently to DRC. The Title 42 rule treats them differently. The CDC's stated rationale is that the discrimination by visa status is necessary to "manage emergency response resources" — that the agency does not have enough capacity to screen and monitor every returning American AND every returning lawful permanent resident, so it screens citizens and bars permanent residents. The "balance" the agency cites is between public health and emergency response capacity. It is not between public health and the WHO's standing position.

The Africa CDC's May 19 statement put the structural answer most directly: "The fastest path to protecting all countries in the world is to aggressively support outbreak control at the source." [10]

Friday's American answer was to bar more people from coming home.

-- NORA WHITFIELD, Chicago